BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Exec. Dir, Finance - PAO Michael L Jones sold $40K of BioCryst Pharmaceuticals, Inc.
Sold$39,560
$17.20Price
2,300Shares
−17%Stake
What BCRX did after the filing
- The stock from Thu, Mar 3 close, $16.48
- −30.9%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Apr 14 close.
Traded Tue, Mar 1. Filed Thu, Mar 3, 12:04 PM ET, during the session. Returns use the Mar 3 close and the Apr 14 close. Not investment advice.